- Home
- DRIO vs HBIO Comparison
DRIO vs HBIO Comparison
Compare DRIO & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- HBIO
- Stock Information
- Founded
- DRIO 2011
- HBIO 1901
- Country
- DRIO United States
- HBIO United States
- Employees
- DRIO N/A
- HBIO N/A
- Industry
- DRIO Medical/Dental Instruments
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- DRIO Health Care
- HBIO Industrials
- Exchange
- DRIO Nasdaq
- HBIO Nasdaq
- Market Cap
- DRIO 21.9M
- HBIO 24.6M
- IPO Year
- DRIO N/A
- HBIO 2000
- Fundamental
- Price
- DRIO $7.11
- HBIO $0.44
- Analyst Decision
- DRIO Strong Buy
- HBIO Buy
- Analyst Count
- DRIO 2
- HBIO 3
- Target Price
- DRIO $50.00
- HBIO $2.50
- AVG Volume (30 Days)
- DRIO 31.2K
- HBIO 478.9K
- Earning Date
- DRIO 11-06-2025
- HBIO 11-06-2025
- Dividend Yield
- DRIO N/A
- HBIO N/A
- EPS Growth
- DRIO N/A
- HBIO N/A
- EPS
- DRIO N/A
- HBIO N/A
- Revenue
- DRIO $27,148,000.00
- HBIO $88,750,000.00
- Revenue This Year
- DRIO $0.74
- HBIO N/A
- Revenue Next Year
- DRIO $19.61
- HBIO $7.13
- P/E Ratio
- DRIO N/A
- HBIO N/A
- Revenue Growth
- DRIO 41.79
- HBIO N/A
- 52 Week Low
- DRIO $7.02
- HBIO $0.28
- 52 Week High
- DRIO $31.00
- HBIO $3.04
- Technical
- Relative Strength Index (RSI)
- DRIO 31.31
- HBIO 41.24
- Support Level
- DRIO $8.91
- HBIO $0.49
- Resistance Level
- DRIO $10.60
- HBIO $0.47
- Average True Range (ATR)
- DRIO 0.98
- HBIO 0.03
- MACD
- DRIO -0.19
- HBIO -0.01
- Stochastic Oscillator
- DRIO 1.61
- HBIO 8.29
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.